Efficacy of α-blocker in improving ureteral stent-related symptoms: a meta-analysis of both direct and indirect comparison

References

• ZimskindPDFetterTRWilkersonJLClinical use of long-term indwelling silicone rubber ureteral splints inserted cystoscopicallyJ Urol19679758408446025928
   PubMed Web of Science ®Google Scholar
• NabiGCookJN’DowJMcClintonSOutcomes of stenting after uncomplicated ureteroscopy: systematic review and meta-analysisBMJ2007334759357217311851
   PubMedGoogle Scholar
• LambADVowlerSLJohnstonRDunnNWisemanOJMeta-analysis showing the beneficial effect of α-blockers on ureteric stent discomfortBJU Int2011108111894190221453351
   PubMed Web of Science ®Google Scholar
• HaleblianGKijvikaiKde la RosetteJPremingerGUreteral stenting and urinary stone management: a systematic reviewJ Urol2008179242443018076928
   PubMed Web of Science ®Google Scholar
• ZhouLCaiXLiHWangKJEffects of α-blockers, antimuscarinics, or combination therapy in relieving ureteral stent-related symptoms: a meta-analysisJ Endourol201529665065625491604
   PubMed Web of Science ®Google Scholar
• IraniJSiquierJPirèsCLefebvreODoréBAubertJSymptom characteristics and the development of tolerance with time in patients with indwelling double-pigtail ureteric stentsBJU Int199984327627910468721
   PubMed Web of Science ®Google Scholar
• JoshiHBStainthorpeAMacDonaghRPKeeleyFXJrTimoneyAGBarryMJIndwelling ureteral stents: evaluation of symptoms, quality of life and utilityJ Urol200316931065106912576847
   PubMed Web of Science ®Google Scholar
• ZhuLFengZZhouQPersonalized therapeutics of α 1-blockers in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasiaClin Interv Aging20151062162225848238
   PubMed Web of Science ®Google Scholar
• RussoALa CroceGCapogrossoPLatest pharmacotherapy options for benign prostatic hyperplasiaExpert Opin Pharmacother201415162319232825164497
   PubMed Web of Science ®Google Scholar
• ThorpeANealDBenign prostatic hyperplasiaLancet200336193661359136712711484
   PubMed Web of Science ®Google Scholar
• DeliveliotisCChrisofosMGougousisEPapatsorisADellisAVarkarakisIMIs there a role for alpha 1-blockers in treating double-J stent-related symptoms?Urology2006671353916413328
   PubMed Web of Science ®Google Scholar
• DamianoRAutorinoRDe SioMGiacobbeAPalumboIMD’ArmientoMEffect of tamsulosin in preventing ureteral stent-related morbidity: a prospective studyJ Endourol200822465165618338955
   PubMed Web of Science ®Google Scholar
• BeddingfieldRPedroRNHinckBKreidbergCFeiaKMongaMAlfuzosin to relieve ureteral stent discomfort: a prospective, randomized, placebo controlled studyJ Urol2009181117017619013590
   PubMed Web of Science ®Google Scholar
• WangCJHuangSWChangCHEffects of specific α-1A/1D blocker on lower urinary tract symptoms due to double-J stent: a prospectively randomized studyUrol Res200937314715219277623
   PubMedGoogle Scholar
• WangCJHuangSWChangCHEffects of tamsulosin on lower urinary tract symptoms due to double-J stent: a prospective studyUrol Int2009831666919641362
   PubMed Web of Science ®Google Scholar
• NavanimitkulNLojanapiwatBEfficacy of tamsulosin 0.4 mg/day in relieving double-J stent-related symptoms: a randomized controlled studyJ Int Med Res20103841436144120926016
   PubMed Web of Science ®Google Scholar
• ShelbaiaAElnasharARole of tamsulosin in improving double-J ureteric stent-related symptomsAfr J Urol2011174111114
   Google Scholar
• MokhtariGShakibaMGhodsiSFarzanAHeidari NejadSEsmaeiliSEffect of terazosin on lower urinary tract symptoms and pain due to double-J stent: a double-blind placebo-controlled randomized clinical trialUrol Int2011871192221597261
   PubMed Web of Science ®Google Scholar
• KuyumcuogluUEryildirimBTuncerMFaydaciGTarhanFOzgülAEffectiveness of medical treatment in overcoming the ureteral double-J stent related symptomsCan Urol Assoc J201266e234e23721914427
   PubMed Web of Science ®Google Scholar
• NazimSMAtherMHAlpha-blockers impact stent-related symptoms: a randomized, double-blind, placebo-controlled trialJ Endourol20122691237124122563773
   PubMed Web of Science ®Google Scholar
• ShalabyEAhmedAMaaroufAYahiaIAliMGhobishARandomized controlled trial to compare the safety and efficacy of tamsulosin, solifenacin, and combination of both in treatment of double-j stent-related lower urinary symptomsAdv Urol2013201375238224235970
   PubMedGoogle Scholar
• TehranchiARezaeiYKhalkhaliHRezaeiMEffects of terazosin and tolterodine on ureteral stent related symptoms: a double-blind placebo-controlled randomized clinical trialInt Braz J Urol201339683284024456787
   PubMed Web of Science ®Google Scholar
• SinghITripathySAgrawalVEfficacy of tamsulosin hydrochloride in relieving “double-J ureteral stent-related morbidity”: a randomized placebo controlled clinical studyInt Urol Nephrol201446122279228325201459
   PubMed Web of Science ®Google Scholar
• DellisAEKeeleyFXJrManolasVSkolarikosAARole of α-blockers in the treatment of stent-related symptoms: a prospective randomized control studyUrology2014831566224210570
   PubMed Web of Science ®Google Scholar
• ParkJYooCHanDHShinDWA critical assessment of the effects of tamsulosin and solifenacin as monotherapies and as a combination therapy for the treatment of ureteral stent-related symptoms: a 2×2 factorial randomized trialWorld J Urol201533111833184025809877
   PubMed Web of Science ®Google Scholar
• El-NahasARTharwatMElsaadanyMMosbahAGaballahMAA randomized controlled trial comparing alpha blocker (tamsulosin) and anticholinergic (solifenacin) in treatment of ureteral stent-related symptomsWorld J Urol Epub201510916
   Web of Science ®Google Scholar
• HigginsJPTAltmanDGGøtzschePCCochrane Bias Methods GroupCochrane Statistical Methods GroupThe Cochrane Collaboration’s tool for assessing risk of bias in randomised trialsBMJ2011343d592822008217
   PubMed Web of Science ®Google Scholar
• UshijimaSUkimuraOOkiharaKMizutaniYKawauchiAMikiTVisual analog scale questionnaire to assess quality of life specific to each symptom of the International Prostate Symptom ScoreJ Urol2006176266567116813918
   PubMed Web of Science ®Google Scholar
• ZieblandSThe short form 36 health status questionnaire: clues from the Oxford region’s normative data about its usefulness in measuring health gain in population surveysJ Epidemiol Community Health19954911021057706993
   PubMed Web of Science ®Google Scholar
• GroupTEQEuroQol-a new facility for the measurement of health-related quality of lifeHealth Policy199016319920810109801
   PubMed Web of Science ®Google Scholar
• JoshiHBOkekeANewnsNKeeleyFXJrTimoneyAGCharacterization of urinary symptoms in patients with ureteral stentsUrology200259451151611927301
   PubMed Web of Science ®Google Scholar
• JoshiHBNewnsNStainthorpeAMacDonaghRPKeeleyFXJrTimoneyAGUreteral stent symptom questionnaire: development and validation of a multidimensional quality of life measureJ Urol200316931060106412576846
   PubMed Web of Science ®Google Scholar
• CoyneKSWeinAJTubaroAThe burden of lower urinary tract symptoms: evaluating the effect of LUTS on health-related quality of life, anxiety and depression: EpiLUTSBJU Int2009103s341119302497
   PubMedGoogle Scholar
• HahnSWilliamsonPRHuttonJLGarnerPFlynnEVAssessing the potential for bias in meta-analysis due to selective reporting of subgroup analyses within studiesStat Med200019243325333611122498
   PubMed Web of Science ®Google Scholar
• DamianoROlivaAEspositoCDe SioMAutorinoRD’ArmientoMEarly and late complications of double pigtail ureteral stentUrol Int200269213614012187045
   PubMed Web of Science ®Google Scholar
• Malone-LeeJShaffuBAnandCPowellCTolterodine: superior tolerability than and comparable efficacy to oxybutynin in individuals 50 years old or older with overactive bladder: a randomized controlled trialJ Urol200116551452145611342895
   PubMed Web of Science ®Google Scholar
• ErturkESessionsAJosephJVImpact of ureteral stent diameter on symptoms and tolerabilityJ Endourol2003172596212689395
   PubMed Web of Science ®Google Scholar
• DamianoRAutorinoRDe SioMDoes the size of ureteral stent impact urinary symptoms and quality of life? A prospective randomized studyEur Urol200548467367816039775
   PubMed Web of Science ®Google Scholar
• CandelaJVBellmanGCUreteral stents: impact of diameter and composition on patient symptomsJ Endourol199711145479048298
   PubMed Web of Science ®Google Scholar
• MiyaokaRMongaMUreteral stent discomfort: etiology and managementIndian J Urol200925445519955667
   PubMedGoogle Scholar
• ParkHKPaickSHKimHGLhoYSBaeSThe impact of ureteral stent type on patient symptoms as determined by the ureteral stent symptom questionnaire: a prospective, randomized, controlled studyJ Endourol201529336737125153249
   PubMedGoogle Scholar
• LeeSJYooCOhCYStent position is more important than α-blockers or anticholinergics for stent-related lower urinary tract symptoms after ureteroscopic ureterolithotomy: a prospective randomized studyKorean J Urol201051963664120856649
   PubMedGoogle Scholar